Cargando…
CC-99677, a novel, oral, selective covalent MK2 inhibitor, sustainably reduces pro-inflammatory cytokine production
BACKGROUND: Mitogen-activated protein kinase (MAPK)-activated protein kinase-2 (MK2) is activated downstream of p38 MAPK and regulates stability of mRNAs encoding inflammatory cytokines. CC-99677 is a novel, irreversible, covalent MK2 inhibitor under development for the treatment of ankylosing spond...
Autores principales: | Gaur, Rajula, Mensah, Kofi A., Stricker, Jason, Adams, Mary, Parton, Anastasia, Cedzik, Dorota, Connarn, Jamie, Thomas, Michael, Horan, Gerald, Schafer, Peter, Mair, Stuart, Palmisano, Maria, Ramírez-Valle, Francisco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386913/ https://www.ncbi.nlm.nih.gov/pubmed/35982464 http://dx.doi.org/10.1186/s13075-022-02850-6 |
Ejemplares similares
-
Modeling and simulation of the endogenous CYP3A induction marker 4β-hydroxycholesterol during enasidenib treatment
por: Li, Yan, et al.
Publicado: (2019) -
Design and Characterization of an Intracellular Covalent Ligand for CC
Chemokine Receptor 2
por: Ortiz Zacarías, Natalia V., et al.
Publicado: (2021) -
Exceptionally Long Covalent CC Bonds—A Local Vibrational Mode Study
por: Delgado, Alexis Antoinette Ann, et al.
Publicado: (2021) -
Adobe Premiere Pro CC
por: Smith, Jerron
Publicado: (2013) -
Adobe Premiere Pro CC
por: Jago, Maxim
Publicado: (2015)